Home › Companies › DYNE THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and DYNE THERAPEUTICS INC.’s Form 8-K, filed June 5, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 30, 2025: 4 items on DYNE THERAPEUTICS INC.’s Form 8-K, filed June 5, 2025: 2 approved · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore DYNE THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are DYNE THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Edward Hurwitz | 62,904,718 | -- | -- | 27,406,392 | 15,360,066 | 70% | Not verified | — |
| Elect Director: Dirk Kersten | 58,322,540 | -- | -- | 31,988,570 | 15,360,066 | 65% | Not verified | — |
| b) The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers. | 74,412,453 | 15,817,102 | 81,555 | -- | 15,360,066 | 82% | Approved | — |
| c) The stockholders of the Company recommended, on a non-binding advisory basis, that future advisory votes on the compensation of the Company's named executive officers be held every year. | 105,567,007 | 19,843 | 84,326 | -- | -- | 99.9% | Approved | — |
Source: DYNE THERAPEUTICS INC., Form 8-K, filed with the SEC on June 5, 2025 — read the filing on EDGAR.
Each item below shows how the 192 asset managers that disclosed a DYNE THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of DYNE THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
65% Majority: yes · of votes cast
Description as filed by funds: To elect two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Dirk Kersten
DYNE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Dirk Kersten”): 58,322,540 for, 31,988,570 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 65% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 18,950,453 for, 9,465,235 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,703,864 | 0 | 0 | 0 | For |
| Fidelity | 5,093,824 | 0 | 0 | 51,651 | For |
| BlackRock | 0 | 0 | 0 | 3,301,280 | Withhold |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 2,620,576 | Withhold |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 4,494 | 0 | 0 | 1,826,857 | Withhold |
| JPMorgan | 1,353,976 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 772,518 | 0 | 0 | 0 | For |
| Charles Schwab | 653,350 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 314,586 | Withhold |
| Equitable | 0 | 0 | 0 | 228,251 | Withhold |
| TIAA | 0 | 0 | 0 | 218,559 | Withhold |
| Exchange Place Advisors Trust | 203,520 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 190,914 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 152,859 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 139,245 | Withhold |
| MERIDIAN FUND INC | 113,936 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 113,799 | Withhold |
| Brighthouse | 45,200 | 0 | 0 | 42,602 | Mixed |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 54,511 | Withhold |
| ProShares | 0 | 0 | 0 | 53,012 | Withhold |
| Global X | 49,606 | 0 | 0 | 0 | For |
| MoA Funds Corp | 0 | 0 | 0 | 48,516 | Withhold |
| Northern Trust | 0 | 0 | 0 | 44,120 | Withhold |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 3 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: To elect two Class II directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Edward Hurwitz
DYNE THERAPEUTICS INC.’s own tally for this item (“Elect Director: Edward Hurwitz”): 62,904,718 for, 27,406,392 withheld, per its Form 8-K filed June 5, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 21,846,677 for, 6,569,011 withheld, 0 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,703,864 | 0 | 0 | 0 | For |
| Fidelity | 5,121,029 | 0 | 0 | 24,446 | For |
| BlackRock | 2,568,951 | 0 | 0 | 732,329 | Mixed |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 2,620,576 | Withhold |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 4,494 | 0 | 0 | 1,826,857 | Withhold |
| JPMorgan | 1,353,976 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 772,518 | 0 | 0 | 0 | For |
| Charles Schwab | 653,350 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 0 | 0 | 314,586 | Withhold |
| Equitable | 131,611 | 0 | 0 | 96,640 | Mixed |
| TIAA | 0 | 0 | 0 | 218,559 | Withhold |
| Exchange Place Advisors Trust | 203,520 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 190,914 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 152,859 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 139,245 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 113,936 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 113,799 | Withhold |
| Brighthouse | 45,200 | 0 | 0 | 42,602 | Mixed |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 54,511 | Withhold |
| ProShares | 0 | 0 | 0 | 53,012 | Withhold |
| Global X | 49,606 | 0 | 0 | 0 | For |
| MoA Funds Corp | 0 | 0 | 0 | 48,516 | Withhold |
| Northern Trust | 0 | 0 | 0 | 44,120 | Withhold |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Combines 4 wordings of this item as funds reported it.
82% Approved · of votes cast
Description as filed by funds: TO VOTE, ON AN ADVISORY BASIS, TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
DYNE THERAPEUTICS INC.’s own tally for this item (“b) The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”): 74,412,453 for, 15,817,102 against — passed, per its Form 8-K filed June 5, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “b) The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,238,880 | 464,984 | 0 | 0 | Mixed |
| Fidelity | 5,118,270 | 27,205 | 0 | 0 | For |
| BlackRock | 732,329 | 2,568,951 | 0 | 0 | Mixed |
| JANUS INVESTMENT FUND | 2,620,576 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 6,166 | 1,825,185 | 0 | 0 | Against |
| JPMorgan | 1,353,976 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 772,518 | 0 | 0 | Against |
| Charles Schwab | 0 | 653,350 | 0 | 0 | Against |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 314,586 | 0 | 0 | Against |
| Equitable | 96,640 | 131,611 | 0 | 0 | Mixed |
| TIAA | 218,559 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 0 | 203,520 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 190,914 | 0 | 0 | Against |
| Victory Capital | 152,859 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 139,245 | 0 | 0 | Against |
| MERIDIAN FUND INC | 0 | 113,936 | 0 | 0 | Against |
| Lincoln Financial | 51,899 | 61,900 | 0 | 0 | Mixed |
| Brighthouse | 74,864 | 0 | 12,938 | 0 | Mixed |
| Direxion Shares ETF Trust | 54,511 | 0 | 0 | 0 | For |
| ProShares | 53,012 | 0 | 0 | 0 | For |
| Global X | 0 | 49,606 | 0 | 0 | Against |
| MoA Funds Corp | 48,516 | 0 | 0 | 0 | For |
| Northern Trust | 44,120 | 0 | 0 | 0 | For |
Fund voting reports, all 56 managers: 20,684,997 for, 7,717,753 against, 12,938 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 9,487,781 | 0 | 0 | 0 | For |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 5,579,200 | 0 | 0 | 0 | For |
| FCPM III SERVICES B.V. | 5,462,846 | 0 | 0 | 0 | For |
| Fidelity | 5,194,486 | 0 | 0 | 0 | For |
| State Street | 40,171 | 3,347,620 | 0 | 0 | Against |
| T. Rowe Price | 3,103,748 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 2,912,641 | 0 | 0 | 0 | For |
| Siren, L.L.C. | 2,717,987 | 0 | 0 | 0 | For |
| TCG Crossover Management, LLC | 2,650,150 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 2,567,610 | 0 | 0 | 0 | For |
| Citadel | 2,478,913 | 0 | 0 | 0 | For |
| VR Adviser, LLC | 2,173,913 | 0 | 0 | 0 | For |
| BlackRock | 265,642 | 1,891,243 | 0 | 0 | Mixed |
| Deep Track Capital, LP | 2,000,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,957,900 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 1,908,533 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 1,640,030 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 1,405,840 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 51,899 | 1,300,871 | 0 | 0 | Against |
| Vestal Point Capital, LP | 1,183,937 | 0 | 0 | 0 | For |
| Vivo Capital, LLC | 1,114,960 | 0 | 0 | 0 | For |
| Logos Global Management LP | 0 | 1,050,000 | 0 | 0 | Against |
| ORBIMED ADVISORS LLC | 0 | 1,014,611 | 0 | 0 | Against |
| ArrowMark Colorado Holdings LLC | 0 | 897,946 | 0 | 0 | Against |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 812,578 | 0 | 0 | 0 | For |
Institutional-manager reports, all 150 managers: 63,233,139 for, 11,802,687 against, 54,739 abstained, 196 not voted, 42,940 1 year. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| WASATCH FUNDS TRUST | 0 | 0 | 0 | 0 | -- |
| Aberdeen | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Exchange Place Advisors Trust | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| MERIDIAN FUND INC | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 51,899 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 0 | 12,938 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| MoA Funds Corp | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 56 managers: 51,899 for, 12,938 abstained, 28,350,851 1 year, 0 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 0 | 0 | 0 | 0 | -- |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 0 | 0 | 0 | 0 | -- |
| FCPM III SERVICES B.V. | 5,462,846 | 0 | 0 | 0 | For |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| Siren, L.L.C. | 0 | 0 | 0 | 0 | -- |
| TCG Crossover Management, LLC | 2,650,150 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 0 | 0 | 0 | 0 | -- |
| Citadel | 0 | 0 | 0 | 0 | -- |
| VR Adviser, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| PERCEPTIVE ADVISORS LLC | 1,908,533 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 0 | 0 | 0 | 0 | -- |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| Vestal Point Capital, LP | 0 | 0 | 0 | 0 | -- |
| Vivo Capital, LLC | 0 | 0 | 0 | 0 | -- |
| Logos Global Management LP | 0 | 0 | 0 | 0 | -- |
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| ArrowMark Colorado Holdings LLC | 0 | 0 | 0 | 0 | -- |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 146 managers: 10,334,817 for, 532 against, 196 not voted, 64,145,762 1 year, 71,496 3 year. Showing the 25 largest; see all in the interactive database.
88% of fund votes cast · no official result
The 3 asset managers below reported 1,742,103 for, 228,261 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 1,742,070 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 0 | 228,261 | 0 | 0 | Against |
| Coyle Financial Counsel LLC | 33 | 0 | 0 | 0 | For |
— of fund votes cast · no official result
The 2 asset managers below reported 1,742,103 1 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Coyle Financial Counsel LLC | 0 | 0 | 0 | 0 | -- |
99.9% of fund votes cast · no official result
Description as filed by funds: TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
The 56 asset managers below reported 28,402,750 for, 0 against, 12,938 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 7,703,864 | 0 | 0 | 0 | For |
| Fidelity | 5,145,475 | 0 | 0 | 0 | For |
| BlackRock | 3,301,280 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 2,620,576 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,092,332 | 0 | 0 | 0 | For |
| State Street | 1,831,351 | 0 | 0 | 0 | For |
| JPMorgan | 1,353,976 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 772,518 | 0 | 0 | 0 | For |
| Charles Schwab | 653,350 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 470,913 | 0 | 0 | 0 | For |
| Aberdeen | 314,586 | 0 | 0 | 0 | For |
| Equitable | 228,251 | 0 | 0 | 0 | For |
| TIAA | 218,559 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 203,520 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 190,914 | 0 | 0 | 0 | For |
| Victory Capital | 152,859 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 139,245 | 0 | 0 | 0 | For |
| MERIDIAN FUND INC | 113,936 | 0 | 0 | 0 | For |
| Lincoln Financial | 113,799 | 0 | 0 | 0 | For |
| Brighthouse | 74,864 | 0 | 12,938 | 0 | Mixed |
| Direxion Shares ETF Trust | 54,511 | 0 | 0 | 0 | For |
| ProShares | 53,012 | 0 | 0 | 0 | For |
| Global X | 49,606 | 0 | 0 | 0 | For |
| MoA Funds Corp | 48,516 | 0 | 0 | 0 | For |
| Northern Trust | 44,120 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 113,633,782 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.78% |
| 2 | Fidelity | 4.53% |
| 3 | BlackRock | 2.91% |
| 4 | JANUS INVESTMENT FUND | 2.31% |
| 5 | T. Rowe Price | 1.84% |
| 6 | State Street | 1.61% |
| 7 | JPMorgan | 1.19% |
| 8 | FRANKLIN STRATEGIC SERIES | 0.68% |
| 9 | Charles Schwab | 0.57% |
| 10 | WASATCH FUNDS TRUST | 0.41% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 8.35% |
| 2 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 4.91% |
| 3 | FCPM III SERVICES B.V. | 4.81% |
| 4 | Fidelity | 4.57% |
| 5 | State Street | 2.98% |
| 6 | T. Rowe Price | 2.73% |
| 7 | RA CAPITAL MANAGEMENT, L.P. | 2.56% |
| 8 | Siren, L.L.C. | 2.39% |
| 9 | TCG Crossover Management, LLC | 2.33% |
| 10 | ARMISTICE CAPITAL, LLC | 2.26% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 12.01% | 13G |
| BlackRock | 7.08% | 13F |
| Vanguard Group | 6.52% | 13F |
| Atlas Venture Fund XI, L.P. | 5.01% | 13G |
| ForDyne B.V. | 4.75% | 13G |
| FMR (Fidelity) | 4.57% | 13F |
| State Street | 3.18% | 13F |
| Citadel Advisors | 2.70% | 13F |
| JPMorgan Chase | 2.23% | 13F |
| Geode Capital | 1.72% | 13F |
Percentages above are of 113,633,782 shares outstanding, as reported by DYNE THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from DYNE THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At DYNE THERAPEUTICS INC.'s shareholder meeting held May 30, 2025, in the 2024-2025 proxy season, 192 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,516 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO VOTE, ON AN ADVISORY BASIS, TO APPROVE THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — DYNE THERAPEUTICS INC.'s filing reports the proposal as approved, with 82% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: DYNE THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2025.
DYNE THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.